Completed
PHASE4
INTERVENTIONAL
NCT03724981
A Study Comparing the Dulaglutide Pen and the Semaglutide Pen
View on ClinicalTrials.gov
Updated Dec 15, 2025
Brief Summary
In this study participants will try out two different types of drug injection pens (dulaglutide and semaglutide) on a practice pad and decide which device they prefer. No study drug will be administered.
Interventions
Name:
Dulaglutide Pen
Type:
DRUG
Description:
Injected on a practice pad.
Name:
Semaglutide Pen
Type:
DRUG
Description:
Injected on a practice pad.
Primary Outcomes
Measure:
Participant Preference Between 2 Injection Devices Based on Global Preference Item
TimeFrame:
Day 1
Description:
Preference of injection device was assessed by questionnaire which asks, "Overall, which device do you prefer?" The Prescott test will be run to examine if a statistically significant difference in preference between the devices exits, while controlling for order effects and taking into account the neutral responses.
Trial Information
NCT ID
NCT03724981
Status
Completed
Study Type
INTERVENTIONAL
Phases
PHASE4
Sponsor
Eli Lilly and Company
Last Updated
December 15, 2025